Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CTLA-4 antibodies and uses thereof

Anti-CTLA-4 antibodies and uses thereof

US Patent 10844137 · Granted Nov 24, 2020

Estimated economic value: $518,210,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-MSR1 antibodies and methods of use thereof2025
Anti-TMPRSS6 antibodies and uses thereof2025
Bispecific anti-PSMA x anti-CD28 antibodies and uses thereof2025
Non-human animals expressing humanized CD3 complex2025
Mouse having a humanized cluster of differentiation 47 gene2025
Mouse having a humanized cluster of differentiation 47 gene2025
Steroids and protein-conjugates thereof2025
Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD2025
Bis-octahydrophenanthrene carboxamides and protein conjugates thereof2025
Therapeutic uses of anti-GITR antibodies2025
Multispecific antigen-binding molecules and uses thereof2025
Antibody-drug conjugates comprising GLP1 peptidomimetics and uses thereof2025